Premature Coronary Artery Disease (CAD) in Severe Psoriasis
NCT00893126 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2016-10-19
Summary
The purpose of this study is to compare the prevalence and severity of CAD (coronary artery disease) in patients with and without severe psoriasis, otherwise matched for cardiovascular risk factors.
Conditions
Interventions
- PROCEDURE
-
CCTA Scan (Coronary CT Angiogram)
CCTA scan will be performed to study and evaluate the prevalence and severity of coronary artery disease (CAD).
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Prachi P Agarwal, M.D. · University of Michigan Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2016-03-31
- Completion
- 2016-08-31
Countries
- United States
Study Locations
More Related Trials
-
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
NCT02144857 ·Status: UNKNOWN ·Phase: PHASE4
-
Subclinical Impairment of Cardiovascular System in Patients With Psoriasis
NCT05957120 ·Status: COMPLETED
-
Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis
NCT00940862 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
NCT04950218 ·Status: RECRUITING
-
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
NCT01356758 ·Status: COMPLETED
-
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
NCT01555606 ·Status: COMPLETED
-
Personal Precise Treatment on Psoriasis and Psoriatic Arthritis
NCT04915105 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
NCT00998829 ·Status: COMPLETED
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
NCT04428411 ·Status: COMPLETED
-
Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis
NCT03889938 ·Status: UNKNOWN
-
The Disease Severity In Patients With Psoriasis
NCT05943405 ·Status: COMPLETED
-
Psoriatic Arthritis D2P Screening
NCT04110522 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
NCT05925842 ·Status: UNKNOWN
-
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
NCT01971346 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients
NCT04083612 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
NCT05835843 ·Status: COMPLETED
-
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT03982394 ·Status: COMPLETED
-
Regulation of Inflammatory Genes in Psoriasis
NCT03125655 ·Status: RECRUITING
-
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
NCT04398732 ·Status: COMPLETED
-
Effect of Adalimumab Therapy on Psoriasis Patient
NCT05889338 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)
NCT03608657 ·Status: COMPLETED
-
Long-Term Follow-Up Study of Psoriasis Patients
NCT00131066 ·Status: COMPLETED
-
Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis
NCT01722214 ·Status: COMPLETED ·Phase: PHASE4
-
Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab
NCT03099083 ·Status: COMPLETED